QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NASDAQ:SLS

SELLAS Life Sciences Group (SLS) Institutional Ownership

$1.71
0.00 (0.00%)
(As of 06/5/2023 ET)
Compare
Today's Range
$1.67
▼
$1.74
50-Day Range
$1.39
▼
$6.15
52-Week Range
$1.17
▼
$5.58
Volume
146,227 shs
Average Volume
347,273 shs
Market Capitalization
$48.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)

Current
Institutional Ownership
Percentage
10.65%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$16.15 M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$5.43 M
Skip Chart & View Institutional Buying and Selling Data

SLS Institutional Buying and Selling by Quarter

Get SLS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


SELLAS Life Sciences Group Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2023State Street Corp97,129$0.14M0.0%+35.4%0.343%
5/15/2023Equitable Holdings Inc.130,000$0.19M0.0%+15.0%0.459%
5/12/2023Dimensional Fund Advisors LP31,304$45K0.0%-46.6%0.110%
5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367%
2/15/2023Virtu Financial LLC18,379$43K0.0%N/A0.089%
2/15/2023Millennium Management LLC61,179$0.14M0.0%+146.9%0.298%
2/13/2023Wells Fargo & Company MN16,140$38K0.0%+44.9%0.079%
2/13/2023Geode Capital Management LLC188,066$0.44M0.0%+30.0%0.915%
2/9/2023Dimensional Fund Advisors LP58,592$0.14M0.0%N/A0.285%
1/18/2023Opus Capital Group LLC19,672$46K0.0%N/A0.096%
11/15/2022State Street Corp58,206$0.12M0.0%+13.6%0.283%
11/15/2022Two Sigma Investments LP53,685$0.11M0.0%+149.8%0.261%
11/15/2022Empery Asset Management LP308,466$0.62M3.7%-66.8%1.501%
11/14/2022Renaissance Technologies LLC22,400$45K0.0%-33.8%0.109%
8/13/2022Renaissance Technologies LLC33,838$75K0.0%N/A0.165%
6/7/2022Bank of America Corp DE21,656$0.15M0.0%-31.9%0.105%
5/16/2022State Street Corp51,236$0.34M0.0%+36.7%0.249%
5/16/2022Prelude Capital Management LLC31,125$0.21M0.0%N/A0.152%
2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066%
2/11/2022Equitable Holdings Inc.102,000$0.56M0.0%+2.0%0.642%
11/12/2021Jump Financial LLC14,627$0.13M0.0%N/A0.092%
11/12/2021Equitable Holdings Inc.100,000$0.92M0.0%+6.0%0.630%
11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843%
8/25/2021Marshall Wace LLP84,544$0.94M0.0%+63.0%0.533%
8/17/2021Price T Rowe Associates Inc. MD15,500$0.17M0.0%-42.8%0.103%
8/16/2021Morgan Stanley15,499$0.17M0.0%+297.4%0.103%
8/16/2021Pinz Capital Management LP10,700$0.12M0.0%-18.3%0.071%
8/16/2021State Street Corp37,468$0.42M0.0%N/A0.248%
8/16/2021Marshall Wace LLP84,544$0.94M0.0%+63.0%0.560%
8/13/2021Northern Trust Corp24,605$0.27M0.0%+35.9%0.163%
8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672%
8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100%
8/12/2021Dimensional Fund Advisors LP20,320$0.23M0.0%+31.9%0.135%
8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724%
8/11/2021Bank of New York Mellon Corp20,332$0.23M0.0%+30.3%0.135%
(Data available from 1/1/2016 forward)













SLS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SLS shares?

During the previous two years, 24 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Vanguard Group Inc. ($6.87M), Highbridge Capital Management LLC ($2.58M), Bank of Montreal Can ($1.43M), Marshall Wace LLP ($0.94M), Empery Asset Management LP ($0.62M), Geode Capital Management LLC ($0.44M), and Northern Trust Corp ($0.27M).Learn more on SLS's institutional investors.

What percentage of SELLAS Life Sciences Group stock is owned by institutional investors?

10.65% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings.

Which institutional investors have been buying SELLAS Life Sciences Group stock?

Of the 20 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.81M), Vanguard Group Inc. ($0.15M), Bank of Montreal Can ($0.11M), State Street Corp ($83.61K), Geode Capital Management LLC ($82.24K), Marshall Wace LLP ($65.37K), and Dimensional Fund Advisors LP ($63.50K).

How much institutional buying is happening at SELLAS Life Sciences Group?

Institutional investors have bought a total of 2,606,934 shares in the last 24 months. This purchase volume represents approximately $25.77M in transactions.

Which SELLAS Life Sciences Group major shareholders have been selling company stock?

The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Empery Asset Management LP ($0.62M), Dimensional Fund Advisors LP ($27.29K), Price T Rowe Associates Inc. MD ($11.60K), Renaissance Technologies LLC ($11.44K), Bank of America Corp DE ($10.14K), and Pinz Capital Management LP ($2.40K).

How much institutional selling is happening at SELLAS Life Sciences Group?

Institutional investors have sold a total of 682,388 shares in the last 24 months. This volume of shares sold represents approximately $5.74M in transactions.


Related Companies:
This page (NASDAQ:SLS) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -